Pure Global

Timing of Soft Tissue Grafting Following Immediate Implant Placement - Trial NCT05537545

Access comprehensive clinical trial information for NCT05537545 through Pure Global AI's free database. This phase not specified trial is sponsored by University Ghent and is currently Recruiting. The study focuses on Bone Resorption. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05537545
Recruiting
procedure
Trial Details
ClinicalTrials.gov โ€ข NCT05537545
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Timing of Soft Tissue Grafting Following Immediate Implant Placement
A Randomized Controlled Trial on the Timing of Soft Tissue Grafting Following Immediate Implant Placement

Study Focus

Bone Resorption

Soft tissue grafting

Interventional

procedure

Sponsor & Location

University Ghent

Ghent, Belgium

Timeline & Enrollment

N/A

Aug 01, 2022

Jul 01, 2028

40 participants

Primary Outcome

Buccal bone resorption (mm)

Summary

Patients undergoing single immediate implant placement (IIP) in the premaxilla will be
 invited to participate in this randomized controlled trial (RCT). Prior to surgery, a small-
 field low-dose cone beam computed tomography (CBCT) is taken to verify the integrity of the
 facial bone wall and an adequate amount of apical and palatal bone availability for implant
 anchorage.
 
 In all of the patients, a connective tissue graft (CTG) will be harvested and inserted into
 the buccal mucosa to increase soft tissue thickness around the immediately installed implant.
 However, included patients will be randomly allocated to either receive the CTG immediately
 after implant installation (Immediate soft tissue grafting, ISG = control group) or 3 months
 after implant installation (Delayed soft tissue grafting, DSG = test group).
 
 Forty sealed envelopes are prepared for that purpose, of which 20 are internally labeled as
 DSG and 20 as ISG. Following IIP, a sealed envelope will be opened to reveal the
 treatment concept In both groups, a cutting implant is installed in an optimal 3D position.
 Socket grafting is performed with deproteinized bovine bone mineral to limit buccal bone
 resorption and to optimize soft tissue stability.
 
 In the ISG group, a pouch is made in the buccal mucosa using microsurgical instruments.
 Thereupon, a free gingival graft is harvested from the palatal mucosa in the premolar area
 and de-epithelialized to arrive at a CTG of about 1 mm thickness. Height and length are
 tailored to the dimensions of the site. Then, the CTG is brought into the pouch and fixed
 with two single sutures onto the buccal mucosa. Finally, a healing abutment is installed,
 which is replaced by a provisional implant crown 2 days later.
 
 In the DSG group, implant placement, socket grafting and installation of a provisional
 implant crown occur as described above. In contrast, a buccal pouch is performed 3 months
 after implant installation. Graft harvesting, adaptation and fixation are performed as
 described above.
 
 A small-field low-dose CBCT is taken at the 1-year and 5-year follow-up in order to measure
 buccal bone resorption as compared to the baseline dimensions in designated software.

ICD-10 Classifications

Osteolysis
Pathological resorption of teeth
Bone donor
Postsurgical malabsorption osteoporosis
Postsurgical malabsorption osteoporosis with pathological fracture

Data Source

ClinicalTrials.gov

NCT05537545

Non-Device Trial